NYSE: OGN Lawsuit Alert: Investors who lost money with Organon & Co. (NYSE: OGN) shares should contact the Shareholders Foundation

Group 1 - A lawsuit has been filed against Organon & Co. by an investor over alleged violations of securities laws, claiming that the company provided misleading statements while concealing material adverse facts [2] - The lawsuit specifically addresses the company's capital allocation priorities, particularly regarding a significant reduction in quarterly dividends by 70% following the acquisition of Dermavant [2] - Investors who purchased shares of Organon & Co. prior to October 2024 are encouraged to contact the Shareholders Foundation for potential options [1][3] Group 2 - The Shareholders Foundation, Inc. is involved in monitoring legal issues related to shareholders and provides information on securities class actions and settlements [3] - The foundation is not a law firm and does not initiate legal actions, but serves as a public service to inform investors [3]